US drugmakers' reports on side effects often incomplete: study
New York
THE main system for keeping track of the dangerous side effects of prescription drugs is deeply flawed, primarily because drugmakers are submitting incomplete information about the problems to the Food and Drug Administration (FDA), according to a new study by a non-profit group that tracks drug-safety issues.
The study, by the Institute for Safe Medicine Practices, found that only about half of reports of serious side effects submitted by manufacturers met basic standards for completeness, containing a patient's age, sex and the date the event took place. Reports collected by the FDA itself, by contrast, were found to meet those basic standards in 85 per cent of cases.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO